CAIN CHRISTOPHER W.
CIK: 0001817733
Director
Primary company: Cogent Biosciences, Inc. (COGT)
CAIN CHRISTOPHER W. is a corporate insider at Cogent Biosciences, Inc. (COGT) filing SEC Form 4 transactions. 11 transactions across 3 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 34,843 | $15.22 | $530K | 34,843 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
Damora Therapeutics, Inc. DMRA | Award | 37,313 | $23.05 | $860K | 37,313 | 3/23/2026 Filed: 3/23/2026 | Filing → |
| Award | 21,000 | - | - | 21,000 | 7/1/2025 Filed: 7/2/2025 | Filing → | |
| Award | 44,700 | - | - | 44,700 | 6/4/2025 Filed: 6/5/2025 | Filing → | |
| Award | 23,017 | - | - | 23,017 | 4/29/2025 Filed: 5/1/2025 | Filing → | |
| Award | 42,000 | $15.58 | $654K | 42,000 | 3/10/2025 Filed: 3/12/2025 | Filing → | |
| Award | 44,700 | - | - | 44,700 | 6/5/2024 Filed: 6/13/2024 | Filing → | |
| Award | 36,700 | $0.00 | $0 | 36,700 | 6/7/2023 Filed: 6/8/2023 | Filing → | |
| Award | 30,700 | $0.00 | $0 | 30,700 | 6/7/2022 Filed: 6/9/2022 | Filing → | |
| Award | 60,000 | $0.00 | $0 | 60,000 | 3/11/2021 Filed: 3/15/2021 | Filing → | |
Unum Therapeutics Inc. UMRX | Award | 28,661 | $0.00 | $0 | 28,661 | 8/27/2020 Filed: 8/31/2020 | Filing → |
Type
Award
Shares
34,843
Price
$15.22
Value
$530K
Damora Therapeutics, Inc.
DMRA
Type
Award
Shares
37,313
Price
$23.05
Value
$860K
Type
Award
Shares
21,000
Price
-
Value
-
Type
Award
Shares
44,700
Price
-
Value
-
Type
Award
Shares
23,017
Price
-
Value
-
Type
Award
Shares
42,000
Price
$15.58
Value
$654K
Type
Award
Shares
44,700
Price
-
Value
-
Type
Award
Shares
36,700
Price
$0.00
Value
$0
Type
Award
Shares
30,700
Price
$0.00
Value
$0
Type
Award
Shares
60,000
Price
$0.00
Value
$0
Unum Therapeutics Inc.
UMRX
Type
Award
Shares
28,661
Price
$0.00
Value
$0
AI Agent
Try asking...